Co-occurrence of Erdheim-Chester disease and clonally evolving acute myeloid leukemia with FLT3-ITD and PTPN11 mutations
Annals of Hematology · 2024
DOI: 10.1007/s00277-024-05842-5 ↗Kurz gefasst
Fallbericht in der Zeitschrift Annals of Hematology, 2024. Verfasst von Xue-Zhu Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 10073…. Hauptthemen laut MEDLINE: Erdheim-Chester Disease, Leukemia, Myeloid, Acute, fms-Like Tyrosine Kinase 3, Protein Tyrosine Phosphatase, Non-Receptor Type 11. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, Beijing Natural Science Haidian Frontier Foundation, National High Level Hospital Clinical Research Funding.
Abstract (Originalsprache)
Erdheim-Chester disease (ECD) is a rare histiocytosis that tends to co-exist with other myeloid malignancies. Here, we use genetic and transcriptomic sequencing to delineate a case of co-occurring BRAFV600E-mutated ECD and acute myeloid leukemia (AML), followed by AML remission and relapse. The AML relapse involved the extinction of clones with KMT2A-AFDN and FLT3-ITD, and the predominance of PTPN11-mutated subclones with distinct transcriptomic features. This case report has highlighted the screening for other myeloid malignancies at the diagnosis of ECD and the clinical significance of PTPN11-mutated AML subclones that require meticulous monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
- State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
- Neuropathological Department, Beijing Tiantan Hospital Affiliated to Capital Medical University, Beijing Neurosurgical Institute, Beijing, China.
- Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China. caoxinxin@pumch.cn.
- State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China. caoxinxin@pumch.cn.
Förderung
- Fundamental Research Funds for the Central Universities
- Beijing Natural Science Haidian Frontier Foundation
- National High Level Hospital Clinical Research Funding
Zitieren
APA
Wang, X. Z., Gao, X. M., Wang, J. M., Cai, H., Li, J., & Cao, X. X. (2024). Co-occurrence of Erdheim-Chester disease and clonally evolving acute myeloid leukemia with FLT3-ITD and PTPN11 mutations. Annals of Hematology. https://doi.org/10.1007/s00277-024-05842-5
Vancouver
Wang XZ, Gao XM, Wang JM, Cai H, Li J, Cao XX. Co-occurrence of Erdheim-Chester disease and clonally evolving acute myeloid leukemia with FLT3-ITD and PTPN11 mutations. Annals of Hematology. 2024. doi:10.1007/s00277-024-05842-5
BibTeX
@article{Wang2024,
author = {Wang, Xue-Zhu and Gao, Xue-Min and Wang, Jun-Mei and Cai, Hao and Li, Jian and Cao, Xin-Xin},
title = {Co-occurrence of Erdheim-Chester disease and clonally evolving acute myeloid leukemia with FLT3-ITD and PTPN11 mutations},
journal = {Annals of Hematology},
year = {2024},
doi = {10.1007/s00277-024-05842-5}
}
EUVIMED